- Market Capitalization, $K 137,108,736
- Shares Outstanding, K 2,624,593
- Annual Sales, $ 24,384 M
- Annual Income, $ 1,335 M
- 60-Month Beta 0.55
- Price/Sales 5.30
- Price/Cash Flow 16.60
- Price/Book 9.89
|Period||Period Low||Period High||Performance|
| || |
+2.48 (+4.99%)since 12/21/20
| || |
+0.59 (+1.14%)since 10/21/20
| || |
+1.36 (+2.68%)since 01/21/20
, /PRNewswire/ -- Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and...
AstraZeneca's (AZN) Enhertu gets EU approval for metastatic HER2-positive breast cancer patients who have received two or more prior anti-HER2-based regimens.
Astrazeneca (AZN) closed the most recent trading day at $52.24, moving -0.63% from the previous trading session.
Gritstone (GRTS) will develop a second generation vaccine candidate against COVID-19 with the potential for both prolonged protection and potency against spike mutants of the virus. Stock rises.
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BABA, GE, AZN, NIO, and BLNK.
Grifols (GRFS) to begin a study in Spain to evaluate a plasma-derived medicine that would provide immediate immunity against COVID-19.
AstraZeneca's (AZN) Enhertu is the first HER2-directed medicine approved in a decade for patients with HER2-positive metastatic gastric cancer.
Top Analyst Reports for Visa, T-Mobile & Union Pacific
Dr. Reddy's (RDY) receives approval from the DCGI to conduct a phase III study on the Sputnik V vaccine for the treatment of COVID-19 in India.
AstraZeneca's (AZN) four-week, fixed-dose regimen (1500 mg) of Imfinzi will reduce patients's medical visits by half, thereby improving patent convenience.
|Value Line Dividend Idx ETF FT|
|Pharmaceutical Vaneck ETF|
|Nasdaq Biotechnology Ishares ETF|
|Ai Powered International Equity ETF|
|Jpmorgan Betabuilders Europe ETF|
|3rd Resistance Point||53.37|
|2nd Resistance Point||53.01|
|1st Resistance Point||52.63|
|1st Support Level||51.88|
|2nd Support Level||51.52|
|3rd Support Level||51.14|